Evidence map›Paper›PMID 35395869›Full record

ArticleScientific reports2022

Impact of wait times on late postprocedural mortality after successful transcatheter aortic valve replacement.

Vincent Roule, Idir Rebouh, Adrien Lemaitre, Rémi Sabatier, Katrien Blanchart, Clément Briet, Mathieu Bignon, Farzin Beygui

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. The implementation of a streamlined TAVI patient pathway across five European countries: BENCHMARK registry.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Fighting time: the critical importance of pre-TAVR mortality risk prediction.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Vincent RouleCHU de Caen Normandie, Service de Cardiologie, 14000, Caen, France. roule-v@chu-caen.fr.
Idir RebouhCHU de Caen Normandie, Service de Cardiologie, 14000, Caen, France.
Adrien LemaitreCHU de Caen Normandie, Service de Cardiologie, 14000, Caen, France.
Rémi SabatierCHU de Caen Normandie, Service de Cardiologie, 14000, Caen, France.
Katrien BlanchartCHU de Caen Normandie, Service de Cardiologie, 14000, Caen, France.
Clément BrietCHU de Caen Normandie, Service de Cardiologie, 14000, Caen, France.
Mathieu BignonCHU de Caen Normandie, Service de Cardiologie, 14000, Caen, France.
Farzin BeyguiCHU de Caen Normandie, Service de Cardiologie, 14000, Caen, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wait times are associated with mortality on waiting list for transcatheter aortic valve replacement (TAVR). Whether longer wait times are associated with long term mortality after successful TAVR remains unassessed. Consecutive patients successfully treated with elective TAVR in our center between January 2013 and August 2019 were included. The primary end point was one-year all-cause mortality. TAVR wait times were defined as the interval from referral date for valve replacement to the date of TAVR procedure. A total of 383 patients were included with a mean wait time of 144.2 ± 83.87 days. Death occurred in 55 patients (14.4%) at one year. Increased wait times were independently associated with a relative increase of 1-year mortality by 2% per week after referral (Adjusted Hazard Ratio 1.02 [1.002-1.04]; p = 0.02) for TAVR. Chronic kidney disease, left ventricular ejection fraction ≤ 30%, access site and STS score were other independent correlates of 1-year mortality. Our study shows that wait times are relatively long in routine practice and associated with increased 1-year mortality after successful TAVR. Such findings underscore the need of strategies to minimize delays in access to TAVR.

Indexed as

Aortic Valve StenosisTranscatheter Aortic Valve ReplacementAortic ValveHumansRegistriesRisk FactorsStroke VolumeTime FactorsTreatment OutcomeVentricular Function, LeftWaiting Lists

Identifiers

PMID35395869
PMCPMC8993919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.